Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combinations comprising siponimod and laquinimod for the treatment of multiple sclerosis

Combinations comprising siponimod and laquinimod for the treatment of multiple sclerosis

US Patent 10537566 · Granted Jan 21, 2020

Estimated economic value: $12,199,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of hidradenitis suppurativa using JAK inhibitors2025
JAK1 pathway inhibitors for the treatment of prurigo nodularis2025
JAK1 pathway inhibitors for the treatment of gastrointestinal disease2024
JAK inhibitor with a vitamin D analog for treatment of skin diseases2024
Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Li2024
JAK1 pathway inhibitors for the treatment of vitiligo2024
Combination therapy comprising JAK pathway inhibitor and rock inhibitor2024
JAK1 pathway inhibitors for the treatment of gastrointestinal disease2023
Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy2022
Treatment of hidradenitis suppurativa using JAK inhibitors2022
Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy2019